Neurons versus herpes simplex virus: The innate immune interactions that contribute to a host-pathogen standoff

Future Virology

Volumn 10, Issue 6, 2015, Pages 699-714

  Rosato, Pamela C ^a   Leib, David A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

autophagy; herpes simplex virus; interferon; latency; neurons

Indexed keywords

INTERFERON; INTERFERON RECEPTOR; PATTERN RECOGNITION RECEPTOR; VIRUS PROTEIN;

AUTOPHAGY; CLINICAL FEATURE; CYTOKINE PRODUCTION; GENE STRUCTURE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IMMEDIATE EARLY GENE; IMMUNE EVASION; INCIDENCE; INNATE IMMUNITY; INTERFERON STIMULATED GENE; LATENT PERIOD; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW; SEROPREVALENCE; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS GENE; VIRUS REACTIVATION; VIRUS REPLICATION; XENOPHAGY;

EID: 84934272377     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.15.45     Document Type: Review

References (126)

1. Arvin A, Campadelli-Fiume G, Mocarski E et al. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge University Press, Cambridge, UK (2007).
2. Kennedy PGE, Steiner I. Recent issues in herpes simplex encephalitis. J. Neurovirol. 19(4), 346-350 (2013).
3. Rowe AM, Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE, Hendricks RL. Herpes keratitis. Prog. Retin. Eye Res. 32, 88-101 (2013).
4. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M Jr, Diamond MS. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat. Med. 19(4), 458-464 (2013).
5. Daffis S, Samuel MA, Suthar MS, Gale M Jr, Diamond MS. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82(21), 10349-10358 (2008).
6. Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79(21), 13350-13361 (2005).
7. Samuel MA, Whitby K, Keller BC et al. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80(14), 7009-7019 (2006).
8. Trottier Jr. MD, Palian BM, Shoshkes Reiss C. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 333(2), 215-225 (2005).
9. Farmer JR, Altschaefl KM, O'Shea KS, Miller DJ. Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation. PLoS ONE 8(3), e58813 (2013).
10. Schultz KLW, Vernon PS, Griffin DE. Differentiation of neurons restricts arbovirus replication and increases expression of the alpha isoform of IRF-7. J. Virol. 89(1), 48-60 (2015).
11. De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW. Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS ONE 5(9), e13076 (2010).
12. Hafezi W, Lorentzen EU, Eing BR et al. Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog. 8(5), e1002679 (2012).
13. Whitley R, Kimberlin DW, Prober CG. Pathogenesis and disease. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, Cambridge, UK (2007).
14. Liu F, Zhou ZH. Comparative virion structures of human herpesviruses. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, Cambridge, UK (2007).
15. Smith G. Herpesvirus transport to the nervous system and back again. Annu. Rev. Microbiol. 66, 153-176 (2012).
16. Honess RW, Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14(1), 8-19 (1974).
17. Wysocka J, Herr W. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem. Sci. 28(6), 294-304 (2003).
18. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56(2), 558-570 (1985).
19. Hay J, Ruyechan WT. Alphaherpesvirus DNA replication. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, Cambridge, UK (2007).
20. Kramer T, Enquist LW. Directional spread of alphaherpesviruses in the nervous system. Viruses 5(2), 678-707 (2013).
21. Roizman B, Sears AE. An inquiry into the mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol. 41, 543-571 (1987).
22. Kristie TM, Vogel JL, Sears AE. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc. Natl Acad. Sci. 96(4), 1229-1233 (1999).
23. Knipe DM, Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Micro. 6(3), 211-221 (2008).
24. Bloom DC, Giordani NV, Kwiatkowski DL. Epigenetic regulation of latent HSV-1 gene expression. Biochim. Biophys. Acta 1799(3-4), 246-256 (2010).
25. Kent JR, Kang W, Miller CG, Fraser NW. Herpes simplex virus latency-associated transcript gene function. J. Neurovirol. 9(3), 285-290 (2003).
26. Ma JZ, Russell TA, Spelman T, Carbone FR, Tscharke DC. Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response. PLoS Pathog. 10(7), e1004237 (2014).
27. Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322(5899), 268-271 (2008).
28. Spruance SL. Cutaneous herpes simplex virus lesions induced by ultraviolet radiation. A review of model systems and prophylactic therapy with oral acyclovir. Am. J. Med. 85(2A), 43-45 (1988).
29. Wald A, Zeh J, Selke S et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342(12), 844-850 (2000).
30. Du T, Zhou G, Roizman B. HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc. Natl. Acad. Sci. USA 108(46), 18820-18824 (2011).
31. Thompson RL, Preston CM, Sawtell NM. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog. 5(3), e1000352 (2009).
32. Xu F, Sternberg MR, Kottiri BJ et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296(8), 964-973 (2006).
33. Hill GM, Ku ES, Dwarakanathan S. Herpes simplex keratitis. Dis. Mon. 60(6), 239-246 (2014).
34. Casrouge A, Zhang S-Y, Eidenschenk C et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314(5797), 308-312 (2006).
35. Dupuis S, Jouanguy E, Al-Hajjar S et al. Impaired response to interferon-[alpha]/[beta] and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33(3), 388-391 (2003).
36. Zhang S-Y, Jouanguy E, Ugolini S et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317(5844), 1522-1527 (2007).
37. Lafaille FG, Pessach IM, Zhang S-Y et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491(7426), 769-773 (2012).
38. Wintergerst U, Kugler K, Harms F, Belohradsky BH, Pfluger T. Therapy of focal viral encephalitis in children with aciclovir and recombinant beta-interferon-results of a placebo-controlled multicenter study. Eur. J. Med. Res. 10(12), 527-531 (2005).
39. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst. Rev. 1, CD002898 (2015).
40. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189(4), 663-672 (1999).
41. Luker GD, Prior JL, Song J, Pica CM, Leib DA. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J. Virol. 77(20), 11082-11093 (2003).
42. Barber GN. STING-dependent cytosolic DNA sensing pathways. Trends Immunol. 35(2), 88-93 (2014).
43. Levy DE, Marié IJ, Durbin JE. Induction and function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1(6), 476-486 (2011).
44. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11(2), 143-154 (2011).
45. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513-545 (2014).
46. Pérez de Diego R, Sancho-Shimizu V, Lorenzo L et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33(3), 400-411 (2010).
47. Conrady CD, Halford WP, Carr DJJ. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection. J. Virol. 85(4), 1625-1633 (2011).
48. Menachery VD, Pasieka TJ, Leib DA. Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J. Virol. 84(19), 9685-9694 (2010).
49. Ida-Hosonuma M, Iwasaki T, Yoshikawa T et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79(7), 4460-4469 (2005).
50. Paladino P, Mossman KL. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 29(9), 599-607 (2009).
51. Lin R, Noyce RS, Collins SE, Everett RD, Mossman KL. The herpes simplex virus ICP0 RING finger domain inhibits IRF3-and IRF7-mediated activation of interferon-stimulated genes. J. Virol. 78(4), 1675-1684 (2004).
52. Taylor KE, Chew MV, Ashkar AA, Mossman KL. Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication. J. Virol. 88(14), 8091-8101 (2014).
53. Diao L, Zhang B, Fan J et al. Herpes virus proteins ICP0 and BICP0 can activate NF-?B by catalyzing I?B? ubiquitination. Cell. Signal. 17(2), 217-229 (2005).
54. Zhang J, Wang K, Wang S, Zheng C. Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-?B activation by interacting with p65/RelA and p50/NF-?B1. J. Virol. 87(23), 12935-12948 (2013).
55. Van Lint AL, Murawski MR, Goodbody RE et al. Herpes simplex virus immediate-early ICP0 protein inhibits toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J. Virol. 84(20), 10802-10811 (2010).
56. Orzalli MH, Conwell SE, Berrios C, DeCaprio JA, Knipe DM. Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA. Proc. Natl Acad. Sci. USA 110(47), e4492-e4501 (2013).
57. Johnson KE, Song B, Knipe DM. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 374(2), 487-494 (2008).
58. Johnson KE, Knipe DM. Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation. Virology 396(1), 21-29 (2010).
59. Xing J, Ni L, Wang S, Wang K, Lin R, Zheng C. Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-?B activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. J. Virol. 87(17), 9788-9801 (2013).
60. Pasieka TJ, Lu B, Crosby SD et al. Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J. Virol. 82(11), 5527-5535 (2008).
61. Pasieka TJ, Lu B, Leib DA. Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. J. Virol. 82(12), 6052-6055 (2008).
62. Cassady KA, Gross M, Roizman B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J. Virol. 72(11), 8620-8626 (1998).
63. Ishioka K, Ikuta K, Sato Y et al. Herpes simplex virus type 1 virion-derived US11 inhibits type 1 interferon-induced protein kinase R phosphorylation. Microbiol. Immunol. 57(6), 426-436 (2013).
64. Sànchez R, Mohr I. Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein. J. Virol. 81(7), 3455-3464 (2007).
65. Kew C, Lui P-Y, Chan C-P et al. Suppression of PACT-induced Type I interferon production by herpes simplex virus 1 US11 protein. J. Virol. 87(24), 13141-13149 (2013).
66. Xing J, Wang S, Lin R, Mossman KL, Zheng C. Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5. J. Virol. 86(7), 3528-3540 (2012).
67. Lussignol M, Queval C, Bernet-Camard M-F et al. The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR. J. Virol. 87(2), 859-871 (2013).
68. Wang S, Wang K, Li J, Zheng C. Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. J. Virol. 87(21), 11851-11860 (2013).
69. Peri P, Mattila RK, Kantola H et al. Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells. Virol. J. 5(1), 140 (2008).
70. Piroozmand A, Koyama AH, Shimada Y, Fujita M, Arakawa T, Adachi A. Role of Us3 gene of herpes simplex virus type 1 for resistance to interferon. Int. J. Mol. Med. 14(4), 641-645 (2004).
71. Wang S, Wang K, Lin R, Zheng C. Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. J. Virol. 87(23), 12814-12827 (2013).
72. Li Y, Zhang C, Chen X et al. ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1. J. Biol. Chem. 286(28), 24785-24792 (2011).
73. Chou J, Kern ER, Whitley RJ, Roizman B. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250(4985), 1262-1266 (1990).
74. Verpooten D, Ma Y, Hou S, Yan Z, He B. Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J. Biol. Chem. 284(2), 1097-1105 (2009).
75. Orvedahl A, Alexander D, Tallóczy Z et al. HSV-1 ICP34.5 confers neurovirulence by targeting the beclin 1 autophagy protein. Cell Host Microbe 1(1), 23-35 (2007).
76. Boutell C, Everett RD. Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J. Gen. Virol. 94(Pt 3), 465-481 (2013).
77. Härle P, Sainz B Jr, Carr DJJ, Halford WP. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology 293(2), 295-304 (2002).
78. Lanfranca MP, Mostafa HH, Davido DJ. HSV-1 ICP0: an E3 ubiquitin ligase that counteracts host intrinsic and innate immunity. Cells 3(2), 438-454 (2014).
79. Mossman KL, Smiley JR. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76(4), 1995-1998 (2002).
80. Mossman KL, Saffran HA, Smiley JR. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74(4), 2052-2056 (2000).
81. Eidson KM, Hobbs WE, Manning BJ, Carlson P, DeLuca NA. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76(5), 2180-2191 (2002).
82. Cuchet-Lourenço D, Anderson G, Sloan E, Orr A, Everett RD. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection. J. Virol. 87(24), 13422-13432 (2013).
83. Sandri-Goldin RM. The many roles of the highly interactive HSV protein ICP27, a key regulator of infection. Future Microbiol. 6(11), 1261-1277 (2011).
84. Read GS, Frenkel N. Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides. J. Virol. 46(2), 498-512 (1983).
85. Sciortino MT, Parisi T, Siracusano G, Mastino A, Taddeo B, Roizman B. The virion host shutoff RNase plays a key role in blocking the activation of protein kinase R in cells infected with herpes simplex virus 1. J. Virol. 87(6), 3271-3276 (2013).
86. Wylie KM, Schrimpf JE, Morrison LA. Increased eIF2alpha phosphorylation attenuates replication of herpes simplex virus 2 VHS mutants in mouse embryonic fibroblasts and correlates with reduced accumulation of the PKR antagonist ICP34.5. J. Virol. 83(18), 9151-9162 (2009).
87. Strelow LI, Leib DA. Role of the virion host shutoff (VHS) of herpes simplex virus type 1 in latency and pathogenesis. J. Virol. 69(11), 6779-6786 (1995).
88. Pasieka TJ, Menachery VD, Rosato PC, Leib DA. Corneal replication is an interferon response-independent bottleneck for virulence of herpes simplex virus type 1 in the absence of virion host shutoff. J. Virol. 86(14), 7692-7695 (2012).
89. Roller RJ, Roizman B. The herpes simplex virus Us11 open reading frame encodes a sequence-specific RNA-binding protein. J. Virol. 64(7), 3463-3470 (1990).
90. Bryant KF, Cox JC, Wang H, Hogle JM, Ellington AD, Coen DM. Binding of herpes simplex virus-1 US11 to specific RNA sequences. Nucleic Acids Res. 33(19), 6090-6100 (2005).
91. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80(10), 5059-5064 (2006).
92. Zaichick SV, Bohannon KP, Hughes A, Sollars PJ, Pickard GE, Smith GA. The herpesvirus VP1/2 protein is an effector of dynein-mediated capsid transport and neuroinvasion. Cell Host Microbe 13(2), 193-203 (2013).
93. Kattenhorn LM, Korbel GA, Kessler BM, Spooner E, Ploegh HL. A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol. Cell. 19(4), 547-557 (2005).
94. Kawaguchi Y. Us3, a multifunctional protein kinase encoded by herpes simplex virus 1: how does it function in vivo? Cornea 32(Suppl. 1), S22-S27 (2013).
95. Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl Acad. Sci. USA 97(11), 6097-6101 (2000).
96. Rampling R, Cruickshank G, Papanastassiou V et al. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther. 7(10), 859-866 (2000).
97. Rosato PC, Leib DA. Intrinsic innate immunity fails to control herpes simplex virus and vesicular stomatitis virus replication in sensory neurons and fibroblasts. J. Virol. 88(17), 9991-10001 (2014).
98. Fadnis PR, Ravi V, Desai A, Turtle L, Solomon T. Innate immune mechanisms in Japanese encephalitis virus infection: effect on transcription of pattern recognition receptors in mouse neuronal cells and brain tissue. Viral Immunol. 26(6), 366-377 (2013).
99. Peltier DC, Simms A, Farmer JR, Miller DJ. Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J. Immunol. 184(12), 7010-7021 (2010).
100. Préhaud C, Mégret F, Lafage M, Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79(20), 12893-12904 (2005).
101. Reinert LS, Harder L, Holm CK et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122(4), 1368-1376 (2012).
102. Delhaye S, Paul S, Blakqori G et al. Neurons produce type I interferon during viral encephalitis. Proc. Natl Acad. Sci. USA 103(20), 7835-7840 (2006).
103. Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J. Virol. 86(20), 11223-11230 (2012).
104. Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 12(3), 334-345 (2012).
105. Nair S, Michaelsen-Preusse K, Finsterbusch K et al. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLoS Pathog. 10(3), e1003999 (2014).
106. Wacher C, Müller M, Hofer MJ et al. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81(2), 860-871 (2007).
107. Wang J, Campbell IL. Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon. J. Virol. 79(13), 8295-8302 (2005).
108. Low-Calle AM, Prada-Arismendy J, Castellanos JE. Study of interferon-? antiviral activity against Herpes simplex virus type 1 in neuron-enriched trigeminal ganglia cultures. Virus Res. 180, 49-58 (2013).
109. Carr DJJ, Al-khatib Khaldun, James CM, Silverman R. Interferon-? suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J. Neuroimmunol. 141(1-2), 40-46 (2003).
110. Svennerholm B, Ziegler R, Lycke E. Herpes simplex virus infection of the rat sensory neuron effects of interferon on cultured cells. Arch. Virol. 104(1-2), 153-156 (1989).
111. Wigdahl B, Smith CA, Traglia HM, Rapp F. Herpes simplex virus latency in isolated human neurons. Proc. Natl Acad. Sci. USA 81(19), 6217-6221 (1984).
112. Wigdahl BL, Ziegler RJ, Sneve M, Rapp F. Herpes simplex virus latency and reactivation in isolated rat sensory neurons. Virology 127(1), 159-167 (1983).
113. Ellison AR, Yang L, Voytek C, Margolis TP. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology 268(1), 17-28 (2000).
114. Lekstrom-Himes JA, LeBlanc RA, Pesnicak L, Godleski M, Straus SE. Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice. J. Virol. 74(14), 6680-6683 (2000).
115. Cantin E, Tanamachi B, Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73(4), 3418-3423 (1999).
116. Liu T, Khanna KM, Carriere BN, Hendricks RL. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75(22), 11178-11184 (2001).
117. Dong X, Levine B. Autophagy and viruses: adversaries or allies? J. Innate Immun. 5(5), 480-493 (2013).
118. Gobeil PAM, Leib DA. Herpes simplex virus? 34.5 interferes with autophagosome maturation and antigen presentation in dendritic cells. MBio. 3(5), e00267-12 (2012).
119. Leib DA, Alexander DE, Cox D, Yin J, Ferguson TA. Interaction of ICP34.5 with Beclin 1 modulates herpes simplex virus type 1 pathogenesis through control of CD4+ T-cell responses. J. Virol. 83(23), 12164-12171 (2009).
120. Komatsu M, Waguri S, Chiba T et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441(7095), 880-884 (2006).
121. Orvedahl A, Levine B. Autophagy and viral neurovirulence. Cell. Microbiol. 10(9), 1747-1756 (2008).
122. Orvedahl A, MacPherson S, Sumpter R, Tallóczy Z, Zou Z, Levine B. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 7(2), 115-127 (2010).
123. Schmeisser H, Bekisz J, Zoon KC. New function of type I IFN: induction of autophagy. J. Interferon Cytokine Res. 34(2), 71-78 (2014).
124. Tallóczy Z, Jiang W, Virgin HW et al. Regulation of starvation-and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc. Natl Acad. Sci. USA 99(1), 190-195 (2002).
125. Tallóczy Z, Virgin HW, Levine B. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2(1), 24-29 (2006).
126. Al-khatib Khaldun, Williams BRG, Silverman RH, Halford W, Carr DJJ. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2', 5'-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology 313(1), 126-135 (2003).